Imidazobenzodiazepines: sleep and performance studies in humans

Area of Science:

• Pharmacology
• Sleep Medicine
• Neuroscience

Background:

• Fast-elimination hypnotics can improve sleep duration but may have varying residual effects.
• Understanding the pharmacokinetic profiles of hypnotics is crucial for balancing efficacy and safety.

Purpose of the Study:

• To compare the hypnotic activity and residual effects of loprazolam and midazolam in healthy men.
• To evaluate the suitability of these imidazobenzodiazepines for different clinical needs, considering their elimination rates.

Main Methods:

• Healthy male subjects received varying doses of loprazolam (0.5-1.5 mg) and midazolam (10-30 mg).
• Sleep electroencephalography, performance tests, and mood assessments were used to evaluate drug activity.
• Pharmacokinetic analysis focused on the fast elimination phases of both compounds.

Main Results:

• Both loprazolam (6-hour elimination) and midazolam (2-hour elimination) demonstrated hypnotic effects.
• Loprazolam showed potential for sustained hypnotic action with acceptable residual activity.
• Midazolam appeared suitable for tasks requiring skilled performance and for managing shift work sleep disturbances.

Conclusions:

• Loprazolam is indicated for sustained hypnotic effect where some residual activity is tolerable.
• Midazolam is a viable option for individuals engaged in skilled activities or experiencing shift work-related sleep issues.
• The choice between loprazolam and midazolam depends on the desired balance between hypnotic duration and residual effects.